Extensive cutaneous Mycobacterium abscessus infection due to contaminated insulin delivery system

QJM: An International Journal of Medicine

Volumn 102, Issue 12, 2009, Pages 881-884

  Bates, T R ^a,b   Keenher, T ^c   O'Reilly, L C ^c   Heath, C H ^a   Flexman, J P ^a   Murray, R J ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOXITIN; CLARITHROMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; KANAMYCIN; NEUTRAL INSULIN; ANTIDIABETIC AGENT; INSULIN;

ADULT; ANTIBIOTIC SENSITIVITY; APPLICATION SITE HYPERPIGMENTATION; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE REPORT; DEVICE INFECTION; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INJECTION SITE INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; LIPOATROPHY; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SKIN BIOPSY; SKIN INFECTION; BACTERIAL SKIN DISEASE; CLASSIFICATION; DIABETES MELLITUS; EQUIPMENT; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM; NEEDLE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

DIABETES MELLITUS; EQUIPMENT CONTAMINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MIDDLE AGED; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; NEEDLES; SKIN DISEASES, BACTERIAL; TREATMENT OUTCOME;

EID: 77950581716     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcp129     Document Type: Article

References (16)

1. Brown-Elliott B, Wallace R Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002; 15:716-46.
2. Villaneuva A, Calderon R, Vargas B, Ruiz F, Aguero S, Zhang Y, et al. Report on an outbreak of post-injection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase chain reaction. Clin Infect Dis 1997; 24:1147-53.
3. Dytoc M, Honish L, Shandro C, Ting P, Chui L, Fiorillo L, et al. Clinical, microbiological, and epidemiological findings of an outbreak of Mycobacterium abscessus hand-and-foot disease. Diag Microbiol Infect Dis 2005; 53:39-45.
4. Moore M, Frerichs M. An unusual acid fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region: report of a case study with a study of the organism, mycobacterium abscessus. J Investig Dermatol 1953; 20:133-69.
5. Meredith F, Sexton D. Mycobacterium abscessus osteomyelitis following a plantar puncture wound. Clin Infect Dis 1996; 23:651-3.
6. Hofling-Lima A, de Freitas D, Sampaio J, Leao S, Contarini P. In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil. Cornea 2005; 24:730-4.
7. Verhelst D, Goffin E, Bodarwe A, Gigi J, Pirson Y. Purple-blue subcutaneous nodules after renal transplantation: not always Kaposi sarcoma. Nephrol Dialysis Transplant 2001; 16:1716-8.
8. Gordon M, Wilson H, Duthie F, Jones B, Field M. When typical is atypical: mycobacterial infection mimicking cutaneous vasculitis. Rheumatol 2002; 41:685-90.
9. Maloney S, Welbel S, Daves B, Adams K, Becker S, Bland L, et al. Mycobacterium abscessus pseudoinfection traced to an automated endoscope washer: utility of epidemiologic and laboratory investigation. J Infect Dis 1994; 169:1166-9.
10. Kelly S. Multiple injection abscesses in a diabetic caused by Mycobacterium chelonae spp abscessus. Clin Exp Dermatol 1987; 12:48-9.
11. Brown B, Wallace R Jr, Onyi G, DeRosas V, Wallace R. Activities of four macrolides including clarithromycin against Mycobacterium fortuitum, Mycobacterium chelonae, and Mycobacterium chelonae-like organisms. Antimicrob Agents Chemother 1992; 36:180-4.
12. Dalovisio J, Pankey G, Wallace R Jr, Jones D. Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 1981; 3:1068-74.
13. Swenson J, Wallace R Jr, Silcox V, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28:807-11.
14. Hodge R Jr, Krongaard L, Sande M, Kaiser D. Multiple use of disposable insulin syringe-needle units. JAMA 1980; 244:266-7.
15. Chlup R, Marsalek E, Bruns W. A prospective study of the hazards of multiple use of disposable syringes and needles in intensified insulin therapy. Diab Med 1990; 7:624-7.
16. WHO. Best infection control practices for intradermal, subcutaneous, and intramuscular injections. Bull World Health Org 2003; 81:491 500.